Breaking News, Promotions & Moves

Center for Breakthrough Medicines Appoints Joerg Ahlgrimm as CEO

Mr. Ahlgrimm joined CBM in September 2020 as chief operating officer.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The Center for Breakthrough Medicines (CBM), an end-to-end advanced therapy contract development and manufacturing organization (CDMO), has appointed Joerg Ahlgrimm as CEO. CBM provides pre-clinical through commercial manufacturing including process development, plasmid DNA, viral vectors, cell banking, cell processing and supporting testing capabilities.   Mr. Ahlgrimm brings over 20 years of expertise in the areas of operations and supply chain management and has served in multi-billion-dollar...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters